Possible Problem With Optipen Pro-1
Should diabetic patients continue to use this product?
- Damla Goksen, MD,
- Sukran Darcan, MD,
- Muammer Buyukinan, MD and
- Emine Kurt, NP
- Department of Pediatric Endocrinology, Ege University Faculty of Medicine, Bornova, Izmir, Turkey
- Address correspondence to Damla Goksen, MD, Ege University Faculty of Medicine, Department of Pediatric Endocrinology, Mithatpasa cad., no. 1114/5, 35290 Guzelyali-Izmir, Turkey. E-mail: damla.goksen{at}ege.edu.tr
Insulin glargine is a modified basal insulin analog that has been recently introduced and is now available worldwide. Insulin glargine is available in 3-ml cartridges that can be used with the OptiPen Pro-1 (Sanofi-Aventis). The Medicines and Healthcare Products Regulatory Agency (MHRA; executive agency of the Department of Health in the U.K., which enhances and safeguards the health of the public by ensuring the effectiveness of medicines and medical devices) has received a significant number of reports concerning difficulties in the operation and use of the OptiPen Pro-1 insulin pen injection system. …
